Ex-drug company CEO charged in $100 million fraud scheme in U.S
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
Jack Kachkar addresses a news conference in Marseille, January 18, 2007. REUTERS/Philippe Laurenson
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
WASHINGTON (Reuters) - The former chief executive of defunct drug company Inyx Inc
Jack Kachkar, 53, of Key Biscayne, Florida, was charged with eight counts of wire fraud in an indictment filed on Aug. 4 and unsealed on Friday, the department said in a news release. It said the scheme led to the closure of Westernbank Puerto Rico in April 2010.
On Friday Kachkar was arrested and made his first court appearance. He could not immediately be reached for comment.
According to the indictment, Kachkar, who served as Inyx chairman and CEO from 2005 to 2007, caused fraudulent customer invoices to be submitted as collateral for loans from Westernbank and embezzled the proceeds for his personal use.
The Justice Department said Kachkar misappropriated about $25 million to buy expensive real estate in Miami, luxury vehicles and a private jet.
Inyx, which had been listed on the Nasdaq exchange, filed for bankruptcy in 2007.
After the closure of Westernbank Puerto Rico, the Federal Deposit Insurance Corporation arranged for its $8.6 billion of deposits to be transferred to Banco Popular de Puerto Rico.
(Reporting by Eric Beech; Editing by Mohammad Zargham and Richard Chang)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Exclusive: Rohingya women say Myanmar soldiers raped them amid crackdown on militants
- Yemen's Houthis launch missile toward Saudi holy city
- Dollar, bond yields stand tall on enhanced Fed rate hike prospects